Invivyd (IVVD) Net Cash Flow (2021 - 2025)
Invivyd (IVVD) posted Net Cash Flow of $141.7 million for Q4 2025, up 183.09% on a QoQ basis from $50.1 million in Q3 2025, and up 477.64% year-over-year from $24.5 million in Q4 2024.
Invivyd (IVVD) Net Cash Flow (2021 - 2025) Analysis & Trends
Invivyd's Net Cash Flow history runs 5 years deep, the most recent figure standing at $141.7 million for Q4 2025.
- Quarterly Net Cash Flow rose 477.64% year-over-year to $141.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $157.3 million (up 219.83% YoY) and the FY2025 annual result came in at $157.3 million, up 219.83% from the prior year.
- Net Cash Flow was $141.7 million for Q4 2025 at Invivyd, up from $50.1 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $301.3 million in Q2 2021 and bottomed at -$196.7 million in Q3 2022.
- A 5-year average of $5.6 million and a median of -$10.6 million in 2022 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow sank 817.08% — and 2025, when it surged 477.64%.
- Invivyd's Net Cash Flow stood at $64.0 million in 2021, then sank by 390.95% to -$186.1 million in 2022, then surged by 110.11% to $18.8 million in 2023, then tumbled by 299.42% to -$37.5 million in 2024, then jumped by 477.64% to $141.7 million in 2025.
- Business Quant data shows IVVD's Net Cash Flow at $141.7 million in Q4 2025, $50.1 million in Q3 2025, and -$13.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 224.46 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 57.19 Mn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | 141.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 141.72 Mn |
| Dec 31, 2025 | 141.72 Mn |
| Sep 30, 2025 | 50.06 Mn |
| Sep 30, 2025 | 50.06 Mn |
| Jun 30, 2025 | -13.18 Mn |
| Jun 30, 2025 | -13.18 Mn |
| Mar 31, 2025 | -21.26 Mn |
| Mar 31, 2025 | -21.26 Mn |
| Dec 31, 2024 | -37.53 Mn |
| Dec 31, 2024 | -37.53 Mn |
| Sep 30, 2024 | -41.01 Mn |
| Sep 30, 2024 | -41.01 Mn |
| Jun 30, 2024 | -41.51 Mn |
| Jun 30, 2024 | -41.51 Mn |
| Mar 31, 2024 | -11.25 Mn |
| Mar 31, 2024 | -11.25 Mn |
| Dec 31, 2023 | 18.82 Mn |
| Dec 31, 2023 | 18.82 Mn |
| Sep 30, 2023 | 59.88 Mn |
| Sep 30, 2023 | 59.88 Mn |